trending Market Intelligence /marketintelligence/en/news-insights/trending/_S5QlawEkmDbrA7lNRXzog2 content esgSubNav
In This List

Phosphagenics to sell BioElixia brand

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Phosphagenics to sell BioElixia brand

Phosphagenics Ltd. agreed to sell its global BioElixia beauty brand to Pure Beauty Australia Pty Ltd., a unit of private investment group CEM Group of Companies.

The deal will allow Pure Beauty to market and expand the BioElixia range, which comprises products that contain Phosphagenics' proprietary drug delivery system called targeted penetration matrix, or TPM. The sale is in line with Phosphagenics' strategic decision to focus on core TPM businesses.

Phosphagenics will receive a A$200,000 up-front payment, ongoing royalties of 5% based on net sales of products containing TPM and payments from an associated 10-year TPM supply agreement.

The transaction is expected to close the week of Aug. 14.

As of Aug. 9, US$1 was equivalent to A$1.27.